PegBio Co., Ltd. (HKG:2565)
Hong Kong · Delayed Price · Currency is HKD 41.76
-2.00 (-4.57%)
At close: Apr 20, 2026
PegBio Market Cap
PegBio has a market cap or net worth of 18.39 billion as of April 20, 2026.
Market Cap
18.39B
Enterprise Value
17.91B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
41.76
Market Cap Chart
Since May 27, 2025, PegBio's market cap has increased from 3.23B to 18.39B, an increase of 469.83%. That is a compound annual growth rate of 593.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 17.82B | -9.16% |
| Dec 31, 2025 | 19.62B | 507.87% |
| May 27, 2025 | 3.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Duality Biotherapeutics | 28.05B |
| TransThera Sciences (Nanjing) | 27.61B |
| Keymed Biosciences | 23.35B |
| Zai Lab | 21.34B |
| Ascletis Pharma | 19.61B |
| Ascentage Pharma Group International | 19.41B |
| Nanjing Leads Biolabs | 16.96B |
| CStone Pharmaceuticals | 14.87B |